Ignite Creation Date:
2025-12-24 @ 12:55 PM
Ignite Modification Date:
2026-01-22 @ 2:26 PM
Study NCT ID:
NCT06173661
Status:
RECRUITING
Last Update Posted:
2025-09-23
First Post:
2023-11-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
Sponsor:
Brigham and Women's Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2023p002389
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |